#PSA test

Every doctor has his or her own take on the situation and what should be done, and very few of those opinions match.

Salvage radiation therapy is now higher on my list of options to consider, but I’m still concerned about potential long-term side effects.

I’ve got some serious thinking to do in the weeks ahead.

Rubraca shrank tumors and lowered PSA levels in men with advanced prostate cancer.

Screening rates for breast, cervical, colorectal and prostate cancer are still below public health targets.

It was pretty clear right from the start that he was of the “continue to monitor; no need to act right away” mindset.

I only met with the doctor once, but I’m confident he would have argued more forcefully if he thought I needed radiation therapy right away.

I was quite pleased with his responses.

The results make me inclined to put off the decision another four months—another four months without the side effects of radiation therapy.

I should have the results online late Friday night. We’ll see…

A recent report suggests reduced screening may be linked to a rise in advanced disease.

The possibility of the cancer not being back is one more variable in an ocean of uncertainty when you’re desperately seeking solid land.

The bad news: My PSA continued its upward climb. The good news: The rate of increase remained constant.

It’s funny. I’m at the point where I’m not at all worked up about the results.